相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Biomechanical effects of teriparatide in women with osteoporosis treated previously with alendronate and risedronate: Results from quantitative computed tomography-based finite element analysis of the vertebral body
Yan Chevalier et al.
BONE (2010)
Back pain during different sequential treatment regimens of teriparatide: results from EUROFORS
George Lyritis et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Differences Between Bisphosphonates in Binding Affinities for Hydroxyapatite
M. A. Lawson et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS (2010)
Efficacy of Continued Alendronate for Fractures in Women With and Without Prevalent Vertebral Fracture: The FLEX Trial
Ann V. Schwartz et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club
J. -J. Body et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Treatment of Osteoporosis with Parathyroid Hormone and Teriparatide
Johannes Pleiner-Duxneuner et al.
CALCIFIED TISSUE INTERNATIONAL (2009)
Sequential Treatment of Severe Postmenopausal Osteoporosis After Teriparatide: Final Results of the Randomized, Controlled European Study of Forsteo (EUROFORS)
Richard Eastell et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Retreatment With Teriparatide One Year After the First Teriparatide Course in Patients on Continued Long-Term Alendronate
Felicia Cosman et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK
J. Compston et al.
MATURITAS (2009)
Bone-forming agents in the management of osteoporosis
Audrey Neuprez et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Update on the treatment of post-menopausal osteoporosis
Zoe Cole et al.
BRITISH MEDICAL BULLETIN (2008)
Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment
Barbara M. Obermayer-Pietsch et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Randomized trial of once-weekly parathyroid hormone (1-84) on bone mineral density and remodeling
Dennis M. Black et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate
Paul D. Miller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis
Steven Boonen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Parathyroid hormone treatment for osteoporosis
Felicia Cosman
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2008)
Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis
Patrick Garnero et al.
CLINICAL CHEMISTRY (2008)
Monitoring teriparatide-associated changes in vertebral microstructure by high-resolution CT in vivo:: Results from the EUROFORS study
Christian Graeff et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
Dennis M. Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis - A randomized trial
Susan L. Greenspan et al.
ANNALS OF INTERNAL MEDICINE (2007)
Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025
Russel Burge et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis
Tony M. Keaveny et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Effects of continuing or stopping alendronate after 5 years of treatment - The Fracture Intervention Trial long-term extension (FLEX): A randomized trial
Dennis M. Black et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
O. Johnell et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: Sequential triple biopsy studies with micro-computed tomography
B Borah et al.
BONE (2006)
Update of current therapeutic options for the treatment of postmenopausal osteoporosis
S Epstein
CLINICAL THERAPEUTICS (2006)
One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis
DM Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Daily and cyclic parathyroid hormone in women receiving alendronate
F Cosman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass
MR McClung et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate
B Ettinger et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Efficacy of risedronate on clinical vertebral fractures within six months
C Roux et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis
JT Harrington et al.
CALCIFIED TISSUE INTERNATIONAL (2004)
Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis
CH Chesnut et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Seven years of treatment with risedronate in women with postmenopausal osteoporosis
DD Mellström et al.
CALCIFIED TISSUE INTERNATIONAL (2004)
The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis
DM Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: A paired study before and after treatment
BM Misof et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience
OH Sorensen et al.
BONE (2003)
Recombinant human parathyroid hormone (1-34) [Teriparatide] improves both cortical and cancellous bone structure
YB Jiang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
A Randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis
JJ Body et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis:: A paired biopsy study
DW Dempster et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
RM Neer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Effect of risedronate on the risk of hip fracture in elderly women
MR McClung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis
JY Reginster et al.
OSTEOPOROSIS INTERNATIONAL (2000)
分享论文
